Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2021-09-07 16:45:30 UTC |
---|
HMDB ID | HMDB0001491 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Pyridoxal 5'-phosphate |
---|
Description | Pyridoxal phosphate, also known as PLP, pyridoxal 5'-phosphate or P5P, is the active form of vitamin B6. It is a coenzyme in a variety of enzymatic reactions. Pyridoxal 5'-phosphate belongs to the class of organic compounds known as pyridoxals and derivatives. Pyridoxals and derivatives are compounds containing a pyridoxal moiety, which consists of a pyridine ring substituted at positions 2,3,4, and 5 by a methyl group, a hydroxyl group, a carbaldehyde group, and a hydroxymethyl group, respectively. Pyridoxal 5'-phosphate is a drug which is used for nutritional supplementation and for treating dietary shortage or imbalance. Pyridoxal 5'-phosphate exists in all living species, ranging from bacteria to humans. In humans, pyridoxal 5'-phosphate is involved in glycine and serine metabolism. Outside of the human body, pyridoxal 5'-phosphate is found, on average, in the highest concentration within cow milk. Pyridoxal 5'-phosphate has also been detected, but not quantified in several different foods, such as soursops, italian sweet red peppers, muscadine grapes, european plums, and blackcurrants. Pyridoxal 5'-phosphate, with regard to humans, has been found to be associated with several diseases such as epilepsy, early-onset, vitamin B6-dependent, odontohypophosphatasia, pyridoxamine 5-prime-phosphate oxidase deficiency, and hypophosphatasia. Pyridoxal 5'-phosphate has also been linked to the inborn metabolic disorder celiac disease. |
---|
Structure | CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14) |
---|
Synonyms | Value | Source |
---|
3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinecarboxaldehyde | ChEBI | 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate | ChEBI | Codecarboxylase | ChEBI | Phosphoric acid mono-(4-formyl-5-hydroxy-6-methyl-pyridin-3-ylmethyl) ester | ChEBI | PLP | ChEBI | Pyridoxal 5'-(dihydrogen phosphate) | ChEBI | Pyridoxal 5-monophosphoric acid ester | ChEBI | Pyridoxal 5-phosphate | ChEBI | Pyridoxal phosphate | ChEBI | PYRIDOXAL-5'-phosphATE | ChEBI | 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphoric acid | Generator | Phosphate mono-(4-formyl-5-hydroxy-6-methyl-pyridin-3-ylmethyl) ester | Generator | Pyridoxal 5'-(dihydrogen phosphoric acid) | Generator | Pyridoxal 5-monophosphate ester | Generator | Pyridoxal 5-phosphoric acid | Generator | Pyridoxal phosphoric acid | Generator | PYRIDOXAL-5'-phosphoric acid | Generator | Pyridoxal 5'-phosphoric acid | Generator | Apolon b6 | HMDB | Biosechs | HMDB | Coenzyme b6 | HMDB | Hairoxal | HMDB | Hexermin-p | HMDB | Hi-pyridoxin | HMDB | Hiadelon | HMDB | Himitan | HMDB | PAL-p | HMDB | Phosphopyridoxal | HMDB | Phosphopyridoxal coenzyme | HMDB | Pidopidon | HMDB | Piodel | HMDB | Pydoxal | HMDB | Pyridoxal p | HMDB | Pyridoxal-p | HMDB | Pyridoxyl phosphate | HMDB | Pyromijin | HMDB | Sechvitan | HMDB | Vitahexin-p | HMDB | Vitazechs | HMDB | Phosphate, pyridoxal | HMDB | Pyridoxal 5 phosphate | HMDB |
|
---|
Chemical Formula | C8H10NO6P |
---|
Average Molecular Weight | 247.1419 |
---|
Monoisotopic Molecular Weight | 247.024573569 |
---|
IUPAC Name | [(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methoxy]phosphonic acid |
---|
Traditional Name | pyridoxal phosphate |
---|
CAS Registry Number | 54-47-7 |
---|
SMILES | CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O |
---|
InChI Identifier | InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14) |
---|
InChI Key | NGVDGCNFYWLIFO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyridoxals and derivatives. Pyridoxals and derivatives are compounds containing a pyridoxal moiety, which consists of a pyridine ring substituted at positions 2,3,4, and 5 by a methyl group, a hydroxyl group, a carbaldehyde group, and a hydroxymethyl group, respectively. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Pyridine carboxaldehydes |
---|
Direct Parent | Pyridoxals and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Pyridoxal
- Aryl-aldehyde
- Monoalkyl phosphate
- Hydroxypyridine
- Methylpyridine
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Vinylogous acid
- Heteroaromatic compound
- Azacycle
- Organopnictogen compound
- Aldehyde
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Malate-Aspartate Shuttle (HMDB: HMDB0001491)
- Glucose-Alanine Cycle (HMDB: HMDB0001491)
- Vitamin B6 Metabolism (HMDB: HMDB0001491)
- Alanine Metabolism (PathBank: SMP0000055)
- Aspartate Metabolism (PathBank: SMP0000067)
- Glutamate Metabolism (PathBank: SMP0000072)
- Taurine and Hypotaurine Metabolism (PathBank: SMP0000021)
- Selenoamino Acid Metabolism (PathBank: SMP0000029)
- Ammonia Recycling (PathBank: SMP0000009)
- Arginine and Proline Metabolism (PathBank: SMP0000020)
- beta-Alanine Metabolism (PathBank: SMP0000007)
- Carnitine Synthesis (PathBank: SMP0000465)
- Catecholamine Biosynthesis (PathBank: SMP0000012)
- Cysteine Metabolism (PathBank: SMP0000013)
- Folate Metabolism (PathBank: SMP0000053)
- Homocysteine Degradation (PathBank: SMP0000455)
- Lysine Degradation (PathBank: SMP0000037)
- Spermidine and Spermine Biosynthesis (PathBank: SMP0000445)
- Phenylalanine and Tyrosine Metabolism (PathBank: SMP0000008)
- Histidine Metabolism (PathBank: SMP0000044)
- Valine, Leucine, and Isoleucine Degradation (PathBank: SMP0000032)
- Methionine Metabolism (PathBank: SMP0000033)
- Tyrosine Metabolism (PathBank: SMP0000006)
- Sphingolipid Metabolism (PathBank: SMP0000034)
- Propanoate Metabolism (PathBank: SMP0000016)
- Starch and Sucrose Metabolism (PathBank: SMP0000058)
- Glycine and Serine Metabolism (PathBank: SMP0000004)
- Porphyrin Metabolism (PathBank: SMP0000024)
- Urea Cycle (PathBank: SMP0000059)
- Tryptophan Metabolism (PathBank: SMP0000063)
- Threonine and 2-Oxobutanoate Degradation (PathBank: SMP0000452)
- Cysteine Biosynthesis  (PathBank: SMP0000821)
- Threonine Biosynthesis (PathBank: SMP0000837)
- Phenylalanine Metabolism (PathBank: SMP0000938)
- Sulfur Metabolism (PathBank: SMP0000939)
- Sulfur Metabolism (Butanesulfonate) (PathBank: SMP0000940)
- Sulfur Metabolism (Propanesulfonate) (PathBank: SMP0000941)
- Sulfur Metabolism (Ethanesulfonate) (PathBank: SMP0000942)
- Sulfur Metabolism (Isethionate) (PathBank: SMP0000943)
- Sulfur Metabolism (Methanesulfonate) (PathBank: SMP0000944)
- Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis (PathBank: SMP0000975)
- Secondary Metabolites: Trehalose Biosynthesis and Metabolism (PathBank: SMP0000984)
- Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis 2 (PathBank: SMP0002059)
- Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis 3 (PathBank: SMP0002060)
- Porphyrin Metabolism  (PathBank: SMP0002363)
- Sphingolipid Metabolism  (PathBank: SMP0002378)
- Starch and Sucrose Metabolism  (PathBank: SMP0002380)
- Vitamin B6 (PathBank: SMP0002387)
- Choline Biosynthesis I (PathBank: SMP0012026)
- Choline Biosynthesis II (PathBank: SMP0012027)
- Plastoquinol-9 Biosynthesis (PathBank: SMP0012043)
- Thio-Molybdenum Cofactor Biosynthesis (PathBank: SMP0012046)
- Glycine Betaine Biosynthesis I (PathBank: SMP0012047)
- Glycine Betaine Biosynthesis II (PathBank: SMP0012048)
- Butanoate Metabolism (PathBank: SMP0012467)
- Phosphatidylcholine Biosynthesis (PathBank: SMP0014205)
- Phosphatidylethanolamine Biosynthesis (PathBank: SMP0014208)
- Isoquinoline Alkaloid Biosynthesis (PathBank: SMP0063471)
- Vitamin B6 Metabolism  (PathBank: SMP0063472)
- Tropane, Piperidine, and Pyridine Alkaloid Biosynthesis (PathBank: SMP0063474)
- Phosphatidylethanolamine Biosynthesis PE(16:0/16:0) (PathBank: SMP0071720)
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:0) (PathBank: SMP0071721)
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(9Z)) (PathBank: SMP0071722)
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(11Z)) (PathBank: SMP0071723)
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:2(9Z,12Z)) (PathBank: SMP0071724)
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0071725)
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0071726)
- Phosphatidylethanolamine Biosynthesis PE(16:0/20:0) (PathBank: SMP0071727)
- Phosphatidylethanolamine Biosynthesis PE(16:0/20:1(11Z)) (PathBank: SMP0071728)
- Phosphatidylethanolamine Biosynthesis PE(16:0/20:1(13Z)) (PathBank: SMP0071729)
- Phosphatidylethanolamine Biosynthesis PE(16:0/22:0) (PathBank: SMP0071730)
- Phosphatidylethanolamine Biosynthesis PE(16:0/22:1(13Z)) (PathBank: SMP0071731)
- Phosphatidylethanolamine Biosynthesis PE(18:0/18:0) (PathBank: SMP0071732)
- Phosphatidylethanolamine Biosynthesis PE(18:0/18:1(9Z)) (PathBank: SMP0071733)
- Phosphatidylethanolamine Biosynthesis PE(18:0/18:1(11Z)) (PathBank: SMP0071734)
- Phosphatidylethanolamine Biosynthesis PE(18:0/18:2(9Z,12Z)) (PathBank: SMP0071735)
- Phosphatidylethanolamine Biosynthesis PE(18:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0071736)
- Phosphatidylethanolamine Biosynthesis PE(18:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0071737)
- Phosphatidylethanolamine Biosynthesis PE(18:0/20:0) (PathBank: SMP0071738)
- Phosphatidylethanolamine Biosynthesis PE(18:0/20:1(11Z)) (PathBank: SMP0071739)
- Phosphatidylethanolamine Biosynthesis PE(18:0/20:1(13Z)) (PathBank: SMP0071740)
- Phosphatidylethanolamine Biosynthesis PE(18:0/22:0) (PathBank: SMP0071741)
- Phosphatidylethanolamine Biosynthesis PE(18:0/22:1(13Z)) (PathBank: SMP0071742)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/18:1(9Z)) (PathBank: SMP0071743)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/18:1(11Z)) (PathBank: SMP0071744)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/18:2(9Z,12Z)) (PathBank: SMP0071745)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0071746)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0071747)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/20:0) (PathBank: SMP0071748)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/20:1(11Z)) (PathBank: SMP0071749)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/20:1(13Z)) (PathBank: SMP0071750)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/22:0) (PathBank: SMP0071751)
- Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/22:1(13Z)) (PathBank: SMP0071752)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/18:1(11Z)) (PathBank: SMP0071753)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/18:2(9Z,12Z)) (PathBank: SMP0071754)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0071755)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0071756)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/20:0) (PathBank: SMP0071757)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/20:1(11Z)) (PathBank: SMP0071758)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/20:1(13Z)) (PathBank: SMP0071759)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/22:0) (PathBank: SMP0071760)
- Phosphatidylethanolamine Biosynthesis PE(18:1(11Z)/22:1(13Z)) (PathBank: SMP0071761)
- Phosphatidylethanolamine Biosynthesis PE(18:2(9Z,12Z)/18:2(9Z,12Z)) (PathBank: SMP0071762)
- Phosphatidylethanolamine Biosynthesis PE(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0071763)
- Phosphatidylethanolamine Biosynthesis PE(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0071764)
- Phosphatidylethanolamine Biosynthesis PE(18:2(9Z,12Z)/20:0) (PathBank: SMP0071765)
- Phosphatidylethanolamine Biosynthesis PE(18:2(9Z,12Z)/20:1(11Z)) (PathBank: SMP0071766)
- Phosphatidylethanolamine Biosynthesis PE(18:2(9Z,12Z)/20:1(13Z)) (PathBank: SMP0071767)
- Phosphatidylethanolamine Biosynthesis PE(18:2(9Z,12Z)/22:0) (PathBank: SMP0071768)
- Phosphatidylethanolamine Biosynthesis PE(18:2(9Z,12Z)/22:1(13Z)) (PathBank: SMP0071769)
- Phosphatidylethanolamine Biosynthesis PE(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0071770)
- Phosphatidylethanolamine Biosynthesis PE(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0071771)
- Phosphatidylethanolamine Biosynthesis PE(18:3(6Z,9Z,12Z)/20:0) (PathBank: SMP0071772)
- Phosphatidylethanolamine Biosynthesis PE(18:3(6Z,9Z,12Z)/20:1(11Z)) (PathBank: SMP0071773)
- Phosphatidylethanolamine Biosynthesis PE(18:3(6Z,9Z,12Z)/20:1(13Z)) (PathBank: SMP0071774)
- Phosphatidylethanolamine Biosynthesis PE(18:3(6Z,9Z,12Z)/22:0) (PathBank: SMP0071775)
- Phosphatidylethanolamine Biosynthesis PE(18:3(6Z,9Z,12Z)/22:1(13Z)) (PathBank: SMP0071776)
- Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0071777)
- Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/20:0) (PathBank: SMP0071778)
- Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/20:1(11Z)) (PathBank: SMP0071779)
- Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/20:1(13Z)) (PathBank: SMP0071780)
- Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/22:0) (PathBank: SMP0071781)
- Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/22:1(13Z)) (PathBank: SMP0071782)
- Phosphatidylethanolamine Biosynthesis PE(20:0/20:0) (PathBank: SMP0071783)
- Phosphatidylethanolamine Biosynthesis PE(20:0/20:1(11Z)) (PathBank: SMP0071784)
- Phosphatidylethanolamine Biosynthesis PE(20:0/20:1(13Z)) (PathBank: SMP0071785)
- Phosphatidylethanolamine Biosynthesis PE(20:0/22:0) (PathBank: SMP0071786)
- Phosphatidylethanolamine Biosynthesis PE(20:0/22:1(13Z)) (PathBank: SMP0071787)
- Phosphatidylethanolamine Biosynthesis PE(20:1(11Z)/20:1(11Z)) (PathBank: SMP0071788)
- Phosphatidylethanolamine Biosynthesis PE(20:1(11Z)/20:1(13Z)) (PathBank: SMP0071789)
- Phosphatidylethanolamine Biosynthesis PE(20:1(11Z)/22:0) (PathBank: SMP0071790)
- Phosphatidylethanolamine Biosynthesis PE(20:1(11Z)/22:1(13Z)) (PathBank: SMP0071791)
- Phosphatidylethanolamine Biosynthesis PE(20:1(13Z)/20:1(13Z)) (PathBank: SMP0071792)
- Phosphatidylethanolamine Biosynthesis PE(20:1(13Z)/22:0) (PathBank: SMP0071793)
- Phosphatidylethanolamine Biosynthesis PE(20:1(13Z)/22:1(13Z)) (PathBank: SMP0071794)
- Phosphatidylethanolamine Biosynthesis PE(22:0/22:0) (PathBank: SMP0071795)
- Phosphatidylethanolamine Biosynthesis PE(22:0/22:1(13Z)) (PathBank: SMP0071796)
- Phosphatidylethanolamine Biosynthesis PE(22:1(13Z)/22:1(13Z)) (PathBank: SMP0071797)
- L-Homomethionine Biosynthesis (PathBank: SMP0121204)
- Rheumatoid arthritis (HMDB: HMDB0001491)
Disease pathway- Primary Hyperoxaluria Type I (PathBank: SMP0000352)
- Pyruvate Carboxylase Deficiency (PathBank: SMP0000350)
- beta-Ketothiolase Deficiency (PathBank: SMP0000173)
- 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency (PathBank: SMP0000137)
- Propionic Acidemia (PathBank: SMP0000236)
- 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency (PathBank: SMP0000138)
- Maple Syrup Urine Disease (PathBank: SMP0000199)
- 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I (PathBank: SMP0000237)
- 3-Methylglutaconic Aciduria Type I (PathBank: SMP0000139)
- 3-Methylglutaconic Aciduria Type III (PathBank: SMP0000140)
- Methylmalonate Semialdehyde Dehydrogenase Deficiency (PathBank: SMP0000384)
- Methylmalonic Aciduria (PathBank: SMP0000200)
- 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency (PathBank: SMP0000243)
- Homocarnosinosis (PathBank: SMP0000385)
- Hyperinsulinism-Hyperammonemia Syndrome (PathBank: SMP0000339)
- Prolidase Deficiency (PD) (PathBank: SMP0000207)
- Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency) (PathBank: SMP0000362)
- Hyperprolinemia Type II (PathBank: SMP0000360)
- Hyperprolinemia Type I (PathBank: SMP0000361)
- Prolinemia Type II (PathBank: SMP0000208)
- Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency) (PathBank: SMP0000188)
- Ornithine Aminotransferase Deficiency (OAT Deficiency) (PathBank: SMP0000363)
- Aromatic L-Aminoacid Decarboxylase Deficiency (PathBank: SMP0000170)
- Isovaleric Aciduria (PathBank: SMP0000238)
- Canavan Disease (PathBank: SMP0000175)
- Hypoacetylaspartia (PathBank: SMP0000192)
- Cystathionine beta-Synthase Deficiency (PathBank: SMP0000177)
- Hypermethioninemia (PathBank: SMP0000341)
- S-Adenosylhomocysteine (SAH) Hydrolase Deficiency (PathBank: SMP0000214)
- Glycine N-Methyltransferase Deficiency (PathBank: SMP0000222)
- Methylenetetrahydrofolate Reductase Deficiency (MTHFRD) (PathBank: SMP0000340)
- Methionine Adenosyltransferase Deficiency (PathBank: SMP0000221)
- GABA-Transaminase Deficiency (PathBank: SMP0000351)
- Glutaric Aciduria Type I (PathBank: SMP0000186)
- Saccharopinuria/Hyperlysinemia II (PathBank: SMP0000239)
- Histidinemia (PathBank: SMP0000191)
- Lactic Acidemia (PathBank: SMP0000313)
- Phenylketonuria (PathBank: SMP0000206)
- Tyrosinemia Type 2 (or Richner-Hanhart Syndrome) (PathBank: SMP0000369)
- Tyrosinemia Type 3 (TYRO3) (PathBank: SMP0000370)
- Acute Intermittent Porphyria (PathBank: SMP0000344)
- Porphyria Variegata (PV) (PathBank: SMP0000346)
- Congenital Erythropoietic Porphyria (CEP) or Gunther Disease (PathBank: SMP0000345)
- Alkaptonuria (PathBank: SMP0000169)
- Hawkinsinuria (PathBank: SMP0000190)
- Tyrosinemia Type I (PathBank: SMP0000218)
- Argininemia (PathBank: SMP0000357)
- Argininosuccinic Aciduria (PathBank: SMP0000003)
- Citrullinemia Type I (PathBank: SMP0000001)
- Ornithine Transcarbamylase Deficiency (OTC Deficiency) (PathBank: SMP0000205)
- Carbamoyl Phosphate Synthetase Deficiency (PathBank: SMP0000002)
- Dimethylglycine Dehydrogenase Deficiency (PathBank: SMP0000242)
- Dihydropyrimidine Dehydrogenase Deficiency (DHPD) (PathBank: SMP0000179)
- Sarcosinemia (PathBank: SMP0000244)
- Gaucher Disease (PathBank: SMP0000349)
- Globoid Cell Leukodystrophy (PathBank: SMP0000348)
- Metachromatic Leukodystrophy (MLD) (PathBank: SMP0000347)
- Malonic Aciduria (PathBank: SMP0000198)
- Methylmalonic Aciduria Due to Cobalamin-Related Disorders (PathBank: SMP0000201)
- Non-Ketotic Hyperglycinemia (PathBank: SMP0000223)
- Hereditary Coproporphyria (HCP) (PathBank: SMP0000342)
- 2-Hydroxyglutric Aciduria (D and L Form) (PathBank: SMP0000136)
- 3-Methylglutaconic Aciduria Type IV (PathBank: SMP0000141)
- Hyperglycinemia, Non-Ketotic (PathBank: SMP0000485)
- Carnosinuria, Carnosinemia (PathBank: SMP0000493)
- Tyrosinemia, Transient, of the Newborn (PathBank: SMP0000494)
- Tyrosine Hydroxylase Deficiency (PathBank: SMP0000497)
- Dopamine beta-Hydroxylase Deficiency (PathBank: SMP0000498)
- beta-Mercaptolactate-Cysteine Disulfiduria (PathBank: SMP0000499)
- Malonyl-CoA Decarboxylase Deficiency (PathBank: SMP0000502)
- Hypophosphatasia (PathBank: SMP0000503)
- Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency (PathBank: SMP0000504)
- Hyperornithinemia with Gyrate Atrophy (HOGA) (PathBank: SMP0000505)
- Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome] (PathBank: SMP0000506)
- L-Arginine:Glycine Amidinotransferase Deficiency (PathBank: SMP0000507)
- gamma-Cystathionase Deficiency (CTH) (PathBank: SMP0000514)
- Homocystinuria, Cystathionine beta-Synthase Deficiency (PathBank: SMP0000515)
- 3-Hydroxyisobutyric Acid Dehydrogenase Deficiency (PathBank: SMP0000521)
- 3-Hydroxyisobutyric Aciduria (PathBank: SMP0000522)
- Isobutyryl-CoA Dehydrogenase Deficiency (PathBank: SMP0000523)
- Isovaleric Acidemia (PathBank: SMP0000524)
- Fabry Disease (PathBank: SMP0000525)
- Krabbe Disease (PathBank: SMP0000526)
- Hyperlysinemia I, Familial (PathBank: SMP0000527)
- Hyperlysinemia II or Saccharopinuria (PathBank: SMP0000528)
- Monoamine Oxidase-A Deficiency (MAO-A) (PathBank: SMP0000533)
- Glycogen Synthetase Deficiency (PathBank: SMP0000552)
- Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis (PathBank: SMP0000553)
- Glycogenosis, Type IV. Amylopectinosis, Anderson Disease (PathBank: SMP0000554)
- Glycogenosis, Type VI. Hers Disease (PathBank: SMP0000555)
- Mucopolysaccharidosis VI. Sly Syndrome (PathBank: SMP0000556)
- Sucrase-Isomaltase Deficiency (PathBank: SMP0000557)
- Succinic Semialdehyde Dehydrogenase Deficiency (PathBank: SMP0000567)
- Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type (PathBank: SMP0000570)
- Pyridoxine Dependency with Seizures (PathBank: SMP0000571)
- 2-Aminoadipic 2-Oxoadipic Aciduria (PathBank: SMP0000719)
- 3-Phosphoglycerate Dehydrogenase Deficiency (PathBank: SMP0000721)
- Cystinosis, Ocular Nonnephropathic (PathBank: SMP0000722)
- Folate Malabsorption, Hereditary (PathBank: SMP0000724)
- Glutaminolysis and Cancer (PathBank: SMP0002298)
- Sarcosine Oncometabolite Pathway (PathBank: SMP0002313)
- 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency (PathBank: SMP0120439)
- Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome] (PathBank: SMP0120571)
Drug action pathway |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 255 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 28 mg/mL | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Pyridoxal 5'-phosphate,1TMS,isomer #1 | CC1=NC=C(COP(=O)(O)O)C(C=O)=C1O[Si](C)(C)C | 2203.8 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,1TMS,isomer #2 | CC1=NC=C(COP(=O)(O)O[Si](C)(C)C)C(C=O)=C1O | 2183.0 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TMS,isomer #1 | CC1=NC=C(COP(=O)(O)O[Si](C)(C)C)C(C=O)=C1O[Si](C)(C)C | 2256.0 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TMS,isomer #1 | CC1=NC=C(COP(=O)(O)O[Si](C)(C)C)C(C=O)=C1O[Si](C)(C)C | 2134.1 | Standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TMS,isomer #1 | CC1=NC=C(COP(=O)(O)O[Si](C)(C)C)C(C=O)=C1O[Si](C)(C)C | 2835.0 | Standard polar | 33892256 | Pyridoxal 5'-phosphate,2TMS,isomer #2 | CC1=NC=C(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(C=O)=C1O | 2195.9 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TMS,isomer #2 | CC1=NC=C(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(C=O)=C1O | 2144.7 | Standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TMS,isomer #2 | CC1=NC=C(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(C=O)=C1O | 2744.2 | Standard polar | 33892256 | Pyridoxal 5'-phosphate,3TMS,isomer #1 | CC1=NC=C(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(C=O)=C1O[Si](C)(C)C | 2270.7 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,3TMS,isomer #1 | CC1=NC=C(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(C=O)=C1O[Si](C)(C)C | 2215.1 | Standard non polar | 33892256 | Pyridoxal 5'-phosphate,3TMS,isomer #1 | CC1=NC=C(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(C=O)=C1O[Si](C)(C)C | 2487.5 | Standard polar | 33892256 | Pyridoxal 5'-phosphate,1TBDMS,isomer #1 | CC1=NC=C(COP(=O)(O)O)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 2478.3 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,1TBDMS,isomer #2 | CC1=NC=C(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O | 2420.3 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TBDMS,isomer #1 | CC1=NC=C(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 2696.5 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TBDMS,isomer #1 | CC1=NC=C(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 2562.4 | Standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TBDMS,isomer #1 | CC1=NC=C(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 3020.2 | Standard polar | 33892256 | Pyridoxal 5'-phosphate,2TBDMS,isomer #2 | CC1=NC=C(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O | 2643.7 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TBDMS,isomer #2 | CC1=NC=C(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O | 2552.0 | Standard non polar | 33892256 | Pyridoxal 5'-phosphate,2TBDMS,isomer #2 | CC1=NC=C(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O | 2949.6 | Standard polar | 33892256 | Pyridoxal 5'-phosphate,3TBDMS,isomer #1 | CC1=NC=C(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 2891.0 | Semi standard non polar | 33892256 | Pyridoxal 5'-phosphate,3TBDMS,isomer #1 | CC1=NC=C(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 2755.5 | Standard non polar | 33892256 | Pyridoxal 5'-phosphate,3TBDMS,isomer #1 | CC1=NC=C(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(C=O)=C1O[Si](C)(C)C(C)(C)C | 2790.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Pyridoxal 5'-phosphate GC-MS (1 MEOX; 3 TMS) | splash10-0gb9-2690000000-c9bacb7e657461e28407 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Pyridoxal 5'-phosphate GC-MS (Non-derivatized) | splash10-0gb9-2690000000-c9bacb7e657461e28407 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Pyridoxal 5'-phosphate GC-EI-TOF (Non-derivatized) | splash10-004j-0910000000-0408f3957221fc9882cd | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Pyridoxal 5'-phosphate GC-EI-TOF (Non-derivatized) | splash10-0gb9-1790000000-b01115fa8b4cfd3612c7 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pyridoxal 5'-phosphate GC-MS (Non-derivatized) - 70eV, Positive | splash10-0002-9520000000-bfd574b2e5355694902a | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pyridoxal 5'-phosphate GC-MS (1 TMS) - 70eV, Positive | splash10-006t-9152000000-26c9f631195663322986 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pyridoxal 5'-phosphate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Pyridoxal 5'-phosphate Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-0f6t-0690000000-4aa57f3f28f0bdef9dcf | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pyridoxal 5'-phosphate Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0fxx-8900000000-ee972556340c61650528 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pyridoxal 5'-phosphate Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-014l-9100000000-3cc29fb51820adecd59c | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pyridoxal 5'-phosphate LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-0002-0090000000-9b86e80a9dd0de14ab59 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pyridoxal 5'-phosphate LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-03dj-9800000000-9313aa9cbf19bc6311c5 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pyridoxal 5'-phosphate LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-0002-9500000000-7ce120a58879e2214ce5 | 2012-08-31 | HMDB team, MONA | |
|
---|